Philips will highlight its comprehensive portfolio of solutions, including four OB/GYN products, further demonstrating its commitment to the needs of clinicians and their patients
|Sydney, Australia – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that three new ultrasound imaging systems, EPIQ 7, EPIQ 5, and ClearVue 650, as well Philips’s latest development in ultrasound imaging systems, VISIQ, will be showcased at the 23rd annual International Society for Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress taking place from 6 – 9 October in Sydney, Australia. These game-changing technologies were developed with clinician and patient needs at the forefront to help physicians more accurately meet the imaging needs of women at every age and stage of life. In addition to offering powerful and innovative features never before seen in ultrasound, such as faster acquisition of the fetal heart volume and the ability to better image patients with high body mass index, these products enhance Philips’ existing ultrasound portfolio by addressing the spectrum of customer needs, from the most complex maternal fetal medicine exams to routine screenings and everything in between.|
"Healthcare delivery mechanisms continue to demand elegant solutions to provide unprecedented standards of care throughout the world and women’s healthcare is at the forefront of these concerns," said Conrad Smits, GM Ultrasound, Philips Healthcare. "By understanding these demands, and offering four game-changing OB/GYN products, Philips is creating the future of healthcare through meaningful innovation that transforms the way care is delivered, especially to women."
One of the innovations featured at ISUOG is the EPIQ ultrasound system, which offers an entirely new level of clinical confidence with a combination of powerful and innovative technologies never before used for ultrasound. With EPIQ, Philips has created a ground-breaking platform with innovations that address emerging challenges in the OB/GYN segment:
- Fetal Heart Navigator (FHN) xMATRIX technology that allows physicians to acquire the fetal heart volume in as little as two seconds, while Philips Fetal Heart Navigator automatically aligns the ductal arch view as baseline for other views
- Extraordinary penetration at higher frequencies for outstanding imaging even on patients with high body mass index where ultrasound has previously been inconclusive
Additionally, EPIQ also features nSIGHT Imaging technology, a never-before used imaging architecture that provides highly detailed ultrasound images and extraordinary temporal resolution. nSIGHT offers a completely new way to form ultrasound images, which allows:
- Highly detailed ultrasound images and extraordinary temporal resolution
- Ability to see new levels of tissue uniformity without the need of critical transmit focal zone placement
- Exceptional penetration at higher frequencies for superb imaging on technically challenging patients
- Reducing the need for costly repeat exams and the exam time by up to 30%
"EPIQ is setting the stage for a new era of ultrasound technology in hospitals and clinics," said Karim Kalache, Professor and Vice Chairman of the Department of Obstetrics at the Charité University Hospital in Berlin, Germany. "The image quality is superb and we are able to acquire enhanced images for patients that are traditionally challenging to image, such as patients with a large body mass index. I am also impressed by the system’s ability to provide whole fetal volume imaging, allowing my patients to experience a full 3D image of their fetus and my staff the ability to make measurements of the 3D image to get clinical information about the fetus."
In addition to EPIQ, Philips is also unveiling for the first time an ultra-portable ultrasound with a tablet display, VISIQ, which lays the foundation for a future portable product line designed to meet the current and future needs of clinicians and patients in an ever-changing healthcare landscape. With VISIQ, Philips is turning a powerful scanner into a smart ultrasound system by incorporating the core imaging technology and software into the head of the transducer. This technology miniaturization allows for crisp, clear, diagnostic images - comparable to cart-based ultrasound systems - in a portable and easy-to-use system.
"Once available, VISIQ has the possibility to impact how and where maternal and fetal care is delivered," said Dr. Michael Ruma, maternal-fetal medicine specialist, Perinatal Associates of New Mexico in Albuquerque, NM. "In using this product in clinical testing, I’ve been impressed with the image quality and ease-of-use of this ultra-portable device."
Australia is scheduled to be one of the first countries in the world to gain access to this technology, scheduled for release in March of 2014.
Adding to the comprehensive portfolio of systems being showcased at ISUOG, Philips is also featuring ClearVue 650. This is the latest addition to the ClearVue family, offering intuitive 3D/4D imaging and unexpected image quality automation tools, such as proprietary Auto Face Reveal, that makes it easy for clinicians to integrate 3D/4D in their routine clinical practice. Due to its modular design and lightweight mobile cart, ClearVue 650 is easy to use, energy-efficient and cost-effective.
Building on the Auto Face Reveal technology, ClearVue 650 also includes a four dimensional imaging technology called Spatio Temporal Image Correlation (STIC) that help clinicians to more quickly diagnose and inform patients about rare or complex heart abnormalities in the fetus.
For more information, please follow this link or stop by the Philips booth 18 at the ISUOG 2013 World Congress event beginning Sunday, 6 October, running through Wednesday, 9 October, to learn more about Philips Ultrasound or speak with a Philips representative on site at ISUOG.